U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The company provides industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of December 31, 2020, it operated 544 outpatient physical therapy clinics in 39 states; and managed 38 physical therapy facilities. The company was founded in 1990 and is based in Houston, Texas.
IPO Year: 1992
Exchange: NYSE
Website: usph.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/7/2024 | $114.00 → $90.00 | Buy → Neutral | BofA Securities |
| 9/22/2023 | $108.00 | Overweight | JP Morgan |
| 6/30/2023 | $138.00 | Buy | BofA Securities |
| 12/14/2021 | $120.00 | Market Perform → Market Outperform | CJS Securities |
| 8/6/2021 | $130.00 → $139.00 | Outperform | Barrington Research |
4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
Barrington Research analyst Michael Petusky maintains US Physical Therapy (NYSE:USPH) with a Outperform and maintains $122 price target.
US Physical Therapy (NYSE:USPH) reported quarterly earnings of $0.51 per share which missed the analyst consensus estimate of $0.56 by 8.93 percent. This is a 13.56 percent decrease over earnings of $0.59 per share from the same period last year. The company reported quarterly sales of $155.675 million which beat the analyst consensus estimate of $153.366 million by 1.51 percent. This is a 4.83 percent increase over sales of $148.509 million the same period last year.
U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced the acquisition of a physical therapy and hand therapy practice with nine clinic locations. USPH acquired a 50% equity interest in the practice for a purchase price of $16.4 million, with the current practice owners retaining a 50% interest. The business currently generates approximately $11.4 million in annual revenues and approximately 65,000 annual visits.
JP Morgan analyst Calvin Sternick maintains US Physical Therapy (NYSE:USPH) with a Overweight and raises the price target from $99 to $117.
The Change In Rate Is Not Retroactive To January 1, 2024
Friday marks the last chance for investors to receive the next dividend payout from US Physical Therapy (NYSE:USPH). What's Happening The company announced on Tuesday that it would pay shareholders a quarterly dividend of 44 cents per share. On Monday, US Physical Therapy will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open 44 cents lower than it would have opened on any other day. In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Monday. Shareholders who own USPH as of the end of Friday's session are eligible to receive the 44 cents divid
Barrington Research analyst Michael Petusky maintains US Physical Therapy (NYSE:USPH) with a Outperform and raises the price target from $120 to $122.
US Physical Therapy (NYSE:USPH) reported quarterly earnings of $0.59 per share which beat the analyst consensus estimate of $0.57 by 3.51 percent. This is a 1.72 percent increase over earnings of $0.58 per share from the same period last year. The company reported quarterly sales of $154.80 million which beat the analyst consensus estimate of $150.27 million by 3.02 percent. This is a 9.65 percent increase over sales of $141.18 million the same period last year.
U.S. Physical Therapy, Inc. (the "Company) (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today announced that Chris Reading, Chief Executive Officer, will participate in the Stephens Annual Investment Conference on Wednesday, November 20, 2024. On the same day, Carey Hendrickson, Chief Financial Officer, will present at the 16th Annual Southwest IDEAS Conference. The presentations will cover an overview of the Company. About U.S. Physical Therapy, Inc. Founded in 1990, U.S. Physical Therapy, Inc. owns and/or manages 754 outpatient physical therapy clinics in 43 states. USPH clinics provide preventative and
Reports Record Quarterly Patient Volume U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today reported results for the three and nine months ended September 30, 2024. FINANCIAL HIGHLIGHTS Adjusted EBITDA (1), a non-Generally Accepted Accounting Principles ("GAAP") measure, was $21.1 million for the three months ended September 30, 2024 ("2024 Third Quarter"), an increase of $2.5 million from $18.6 million in the three months ended September 30, 2023 ("2023 Third Quarter"). Operating Results (1), a non-GAAP measure, was $10.4 million in the 2024 Third Qua
U.S. Physical Therapy, Inc. ("USPH") (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, closed the previously announced acquisition of a 50% equity interest in a management services organization (the "Company") that provides management and administrative services to 50 outpatient physical therapy clinics, the majority of which are in New York, with plans to further expand in New York and adjacent states. The Company-managed clinics deliver physical, occupational and speech therapy in outpatient clinics, and also provide physical therapy services to patients in their homes. Through its managed therapy providers, the
U.S. Physical Therapy, Inc. (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that it will report its financial results for the three and nine months ended September 30, 2024, on Tuesday, November 5, 2024, after the stock market closes, with the conference call to follow the next morning, on Wednesday, November 6, 2024. Conference Call Date: Wednesday, November 6, 2024 Time: 10:30 am Eastern/9:30 am Central Dial-In Number: (800) 245-3047 Primary or (203) 518-9765 Alternate Conference ID: USPHQ324 (In order to join this conference call, you will be required
U.S. Physical Therapy, Inc. ("USPH") (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today announced that it has signed an agreement to purchase a 50% equity interest in a management services organization (the "Company") that provides management and administrative services to 50 physical therapy clinics. The Company expects to close the transaction on October 31, 2024. The Company manages 50 outpatient clinics, the majority of which are in New York, with plans to further expand in New York and adjacent states. The Company-managed clinics deliver physical, occupational and speech therapy and also provide physical
U.S. Physical Therapy, Inc. (the "Company") (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced the acquisition of a physical therapy and hand therapy practice with eight clinic locations located in Pennsylvania which currently generates approximately $5.5 million in annual revenues. The Company acquired a 70% interest in the Company with the current owners retaining a 30% ownership interest. About U.S. Physical Therapy, Inc. Founded in 1990, U.S. Physical Therapy, Inc. operates 687 outpatient physical therapy clinics in 42 states. The Company's clinics provide preventative and post-operative care for a
U.S. Physical Therapy, Inc. (the "Company) (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today announced that Chris Reading, the Company's Chairman and Chief Executive Officer, will present at the 15th Annual Midwest IDEAS Investor Conference on Wednesday, August 28, 2024. The presentation will cover an overview of the Company. About U.S. Physical Therapy, Inc. Founded in 1990, U.S. Physical Therapy, Inc. operates 680 outpatient physical therapy clinics in 42 states. The Company's clinics provide preventative and post-operative care for a variety of orthopedic-related disorders and sports-related injuries,
Reports All-Time High Quarterly Patient Volume Management Updates Guidance U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today reported results for the three and six months ended June 30, 2024. FINANCIAL HIGHLIGHTS Adjusted EBITDA (1), a non-Generally Accepted Accounting Principles ("GAAP") measure, was $22.1 million for the three months ended June 30, 2024 ("2024 Second Quarter") compared to $21.7 million in the second quarter ended June 30, 2023 ("2023 Second Quarter"). Operating Results (1), a non-GAAP measure, was $11.0 million in the 2024 Se
U.S. Physical Therapy, Inc. (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that it will report its financial results for the three and six months ended June 30, 2024, on Tuesday, August 13, 2024, after the stock market closes, with the conference call to follow the next morning, on Wednesday, August 14, 2024. Conference Call Date: Wednesday, August 14, 2024 Time: 10:30 am Eastern/9:30 am Central Dial-In Number: (800) 245-3047 Primary or (203) 518-9765 Alternate Conference ID: USPHQ224 (In order to join this conference call,
U.S. Physical Therapy, Inc. (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today announced that Chris Reading, Chief Executive Officer, will present at the CJS Securities 24th Annual New Ideas Summer Conference on Wednesday, July 10, 2024. The presentation will cover an overview of the Company. About U.S. Physical Therapy, Inc. Founded in 1990, U.S. Physical Therapy, Inc. operates 682 outpatient physical therapy clinics in 42 states. The Company's clinics provide preventative and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, treatment for neurologically-relate
4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
EAGAN, Minn., June 20, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ:POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, Clinical Laboratory Improvement Amendments (CLIA) laboratory and Good Manufacturing Practices (GMP) facility, to accelerate oncology drug discovery and enable drug development, today announced the appointment of Dr. Bernard A. Harris, Jr. to its newly-formed Business Advisory Board (BAB). "I am very pleased to welcome Dr. Harris to our new Business Advisory Board," said Raymond F. Vennare, Chief Executive Officer of Predictive Oncology. "As we continue
~Highly Esteemed Growth Strategist and Financial Expert with Decades of Business Acumen~ NEW YORK, Oct. 18, 2022 /PRNewswire/ -- The National Kidney Foundation (NKF) is pleased to announce the appointment of Anne Motsenbocker to its national Board of Directors. We're honored & excited Anne has joined the national board to share her extensive business acumen in board governance.Motsenbocker resides in Dallas, Texas and is a former banker and seasoned board member bringing over 35 years of commercial banking and wealth management expertise due to the numerous roles she held at J
HOUSTON, June 10, 2022 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, technology-enabled healthcare services company comprised of a hospital division with 21 facilities in 8 states and a primary care-centric, risk-bearing population health management division, today announced the appointment of Jon Bates as the Company's Chief Financial Officer effective on or about June 30, 2022. On May 3, 2022, Michael Bowen notified the company that he intends to retire as Chief Financial Officer of the Company. In connection with Mr. Bowen's retirement, the Company's Board formed a search committee. On June 8, 2022, the Company announced the appointme
U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today announced that its Board of Directors has appointed Anne Motsenbocker to serve on the Board, effective January 1, 2022. Ms. Motsenbocker served in numerous executive leadership roles in her 36-year career at J.P. Morgan Chase, ultimately serving as the Managing Director and Segment Head of Southwest Middle Market Banking, covering a multi-state region. Previous executive roles at J.P. Morgan Chase included National Head of Multinational Corporations, Chairman of Dallas Market Leadership, President of Dalla
SC 13G/A - U S PHYSICAL THERAPY INC /NV (0000885978) (Subject)
SC 13G - U S PHYSICAL THERAPY INC /NV (0000885978) (Subject)
SC 13G - U S PHYSICAL THERAPY INC /NV (0000885978) (Subject)
SC 13G/A - U S PHYSICAL THERAPY INC /NV (0000885978) (Subject)
SC 13G - U S PHYSICAL THERAPY INC /NV (0000885978) (Subject)
SC 13G/A - U S PHYSICAL THERAPY INC /NV (0000885978) (Subject)
SC 13G/A - U S PHYSICAL THERAPY INC /NV (0000885978) (Subject)
SC 13G/A - U S PHYSICAL THERAPY INC /NV (0000885978) (Subject)
SC 13G/A - U S PHYSICAL THERAPY INC /NV (0000885978) (Subject)
SC 13G/A - U S PHYSICAL THERAPY INC /NV (0000885978) (Subject)
BofA Securities downgraded U.S. Physical Therapy from Buy to Neutral and set a new price target of $90.00 from $114.00 previously
JP Morgan initiated coverage of U.S. Physical Therapy with a rating of Overweight and set a new price target of $108.00
BofA Securities initiated coverage of U.S. Physical Therapy with a rating of Buy and set a new price target of $138.00
CJS Securities upgraded U.S. Physical Therapy from Market Perform to Market Outperform and set a new price target of $120.00
Barrington Research reiterated coverage of U.S. Physical Therapy with a rating of Outperform and set a new price target of $139.00 from $130.00 previously
Barrington Research upgraded U.S. Physical Therapy from Mkt Perform to Outperform and set a new price target of $130.00
Jefferies upgraded U.S. Physical Therapy from Hold to Buy and set a new price target of $135.00 from $130.00 previously
Barrington Research resumed coverage of U.S. Physical Therapy with a rating of Market Perform
Barrington Research downgraded U.S. Physical Therapy from Outperform to Mkt Perform
8-K - U S PHYSICAL THERAPY INC /NV (0000885978) (Filer)
8-K - U S PHYSICAL THERAPY INC /NV (0000885978) (Filer)
10-Q - U S PHYSICAL THERAPY INC /NV (0000885978) (Filer)
8-K - U S PHYSICAL THERAPY INC /NV (0000885978) (Filer)
8-K - U S PHYSICAL THERAPY INC /NV (0000885978) (Filer)
8-K - U S PHYSICAL THERAPY INC /NV (0000885978) (Filer)
8-K - U S PHYSICAL THERAPY INC /NV (0000885978) (Filer)
8-K - U S PHYSICAL THERAPY INC /NV (0000885978) (Filer)
10-Q - U S PHYSICAL THERAPY INC /NV (0000885978) (Filer)
8-K - U S PHYSICAL THERAPY INC /NV (0000885978) (Filer)
U.S. Physical Therapy, Inc. (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that it will report its financial results for the three and nine months ended September 30, 2024, on Tuesday, November 5, 2024, after the stock market closes, with the conference call to follow the next morning, on Wednesday, November 6, 2024. Conference Call Date: Wednesday, November 6, 2024 Time: 10:30 am Eastern/9:30 am Central Dial-In Number: (800) 245-3047 Primary or (203) 518-9765 Alternate Conference ID: USPHQ324 (In order to join this conference call, you will be required
U.S. Physical Therapy, Inc. (the "Company") (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced the acquisition of a physical therapy and hand therapy practice with eight clinic locations located in Pennsylvania which currently generates approximately $5.5 million in annual revenues. The Company acquired a 70% interest in the Company with the current owners retaining a 30% ownership interest. About U.S. Physical Therapy, Inc. Founded in 1990, U.S. Physical Therapy, Inc. operates 687 outpatient physical therapy clinics in 42 states. The Company's clinics provide preventative and post-operative care for a
U.S. Physical Therapy, Inc. (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that it will report its financial results for the three and six months ended June 30, 2024, on Tuesday, August 13, 2024, after the stock market closes, with the conference call to follow the next morning, on Wednesday, August 14, 2024. Conference Call Date: Wednesday, August 14, 2024 Time: 10:30 am Eastern/9:30 am Central Dial-In Number: (800) 245-3047 Primary or (203) 518-9765 Alternate Conference ID: USPHQ224 (In order to join this conference call,
Management Raises Full Year 2024 Guidance U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today reported results for the first quarter ended March 31, 2024. FINANCIAL HIGHLIGHTS Adjusted EBITDA (1), a non-Generally Accepted Accounting Principles ("GAAP") measure, was $16.7 million for the first quarter ended March 31, 2024 ("2024 First Quarter") compared to $18.5 million in the first quarter ended March 31, 2023 ("2023 First Quarter"), with the variance due to the Medicare rate reductions that took effect at the beginning of 2024 and the impact of signi
The Company Acquired an Industrial Injury Prevention Business and a Physical Therapy Practice U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services ("IIP"), announced the acquisition of an IIP services business by one of its primary IIP companies, Briotix Health Limited Partnership ("Briotix"). Briotix purchased 100% of the IIP services business for a total purchase price of approximately $24.0 million. The business currently generates approximately $11.0 million in annual revenues. In a separate transaction, USPH also acquired a two-clinic physical therapy practic
U.S. Physical Therapy, Inc. (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that it will report its financial results for the first quarter ended March 31, 2024, on Tuesday, May 7, 2024, after the stock market closes, with the conference call to follow the next morning, on Wednesday, May 8, 2024. Conference Call Date: Wednesday, May 8, 2024 Time: 10:30 am Eastern/9:30 am Central Dial-In Number: (800) 267-6316 Primary or (203) 518-9783 Alternate Conference ID: USPHQ12
U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced the acquisition of a physical therapy and hand therapy practice with nine clinic locations. USPH acquired a 50% equity interest in the practice for a purchase price of $16.4 million, with the current practice owners retaining a 50% interest. The business currently generates approximately $11.4 million in annual revenues and approximately 65,000 annual visits. Chris Reading, Chief Executive Officer, said, "This will be a great partnership addition to an already strong market for us. Our newest partne
U.S. Physical Therapy, Inc. (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that it will report its financial results for the fourth quarter and year ended December 31, 2023 on Wednesday, February 28, 2024, after the stock market closes, with the conference call to follow the next morning, on Thursday, February 29, 2024. Conference Call Date: Thursday, February 29, 2024 Time: 10:30 am Eastern/9:30 am Central Dial-In Number: (800) 267-6316 Primary or (203) 518-9783 Alternate Conference ID: USPHQ423 (In order to join this conference call, you will be required to provide the Conference ID listed above)
U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention ("IIP") services, today announced the acquisition of an IIP services and ergonomics software business by one of its two primary IIP companies, Briotix Health Limited Partnership ("Briotix"). In addition to increasing its IIP services business, the newly created ergonomics software provides an exciting new solution to add to Briotix's offerings to existing and potential customers. Briotix purchased all of the IIP services business and a 55% equity interest in the ergonomics software business for a total purchase price of
U.S. Physical Therapy, Inc. (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that it will report its financial results for the three and nine months ended September 30, 2023 on Tuesday, November 7, 2023, after the stock market closes, with the conference call to follow the next morning, on Wednesday, November 8, 2023. Conference Call Date: Wednesday, November 8, 2023 Time: 10:30 am Eastern/9:30 am Central Dial-In Number: (800) 274-8461 Primary or (203) 518-9814 Alternate Conference ID: USPHQ323 (In order to join this conference call, you will be required to provide the Conference ID listed above)